
R 59022
CAS No. 93076-89-2
R 59022( R 59-022 | R59022 )
Catalog No. M16660 CAS No. 93076-89-2
A small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 2.8 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 231 | Get Quote |
![]() ![]() |
50MG | 896 | Get Quote |
![]() ![]() |
100MG | 1422 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameR 59022
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 2.8 uM.
-
DescriptionA small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 2.8 uM, inhibits the phosphorylation of OAG to OAPA with IC50 of 3.8 uM in intact platelets; concomitantly stimulates PKC activity, selectively suppresses U46619-induced enhancement of mouse portal vein contraction under high glucose conditions; also induces caspase-mediated apoptosis in glioblastoma cells and in other cancers, but lacks toxicity in noncancerous cells.
-
In VitroWestern Blot Analysis Cell Line:HeLa cells Concentration:40 uM Incubation Time:30 min Result:Increased the phosphorylation of PKC downstream targets by about 2.5-fold.
-
In VivoAnimal Model:SCID mice implanted with U87 GBM cells Dosage:10 mg/kg Administration:Intraperitoneal injection (i.p.) Result:Increased median survival and decreased tumor volume.
-
SynonymsR 59-022 | R59022
-
PathwayOthers
-
TargetDGK
-
RecptorDGK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number93076-89-2
-
Formula Weight459.58
-
Molecular FormulaC27H26FN3OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (135.99 mM)
-
SMILESO=C1C(CCN2CC/C(CC2)=C(C3=CC=C(F)C=C3)\C4=CC=CC=C4)=C(C)N=C5N1C=CS5
-
Chemical Name6-[2-[4-[(4-Fluorophenyl)phenylmethylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dominguez CL, et al. Cancer Discov. 2013 Jul;3(7):782-97.
2. de Chaffoy de Courcelles DC, et al. J Biol Chem. 1985 Dec 15;260(29):15762-70.
3. Nunn DL, et al. Biochem J. 1987 May 1;243(3):809-13.
4. Nobe K, et al. Br J Pharmacol. 2004 Sep;143(1):166-78.
molnova catalog



related products
-
CU-3
CU-3 (DGKα inhibitor CU-3) is a novel potent, selective diacylglycerol kinase α (DGKα) inhibitor with IC50 of 0.6 uM.
-
R-59949
A small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 0.01-10 uM in isolated platelet membranes and in intact platelets.
-
R 59022
A small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 2.8 uM.